<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">Chang et al. carried out studies on COVID-19 patients by giving favipiravir versus Arbidol. Total 240 patients were taken. Among them, 120 patients were given treatments of favipiravir and 120 patients were given the treatments of Arbidol. It was found that no difference was seen in both treatments after 7 days. Favipiravir showed significant relief in cough and pyrexia after 7 days treatments [
 <xref rid="bb0215" ref-type="bibr">43</xref>].
</p>
